131 related articles for article (PubMed ID: 38019185)
21. The Prevalence of Hemoglobinopathies in Young Adolescents in the Province of Muğla in Turkey: Results of a Screening Program.
Topal Y; Topal H; Ceyhan MN; Azik F; Çapanoğlu M; Kocabaş CN
Hemoglobin; 2015; 39(4):247-50. PubMed ID: 26120034
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of beta-thalassemia trait and abnormal hemoglobins in the province of Adıyaman, Turkey.
Genc A; Tastemir Korkmaz D; Urhan Kucuk M; Rencuzogullari E; Atakur S; Bayram S; Onderci M; Koc T; Aslan S; Mutalip A; Faruk M; Sevgiler Y; Tuncdemir A
Pediatr Hematol Oncol; 2012 Oct; 29(7):620-3. PubMed ID: 22897698
[TBL] [Abstract][Full Text] [Related]
23. Prevalence and mutations of β-thalassemia trait and abnormal hemoglobins in premarital screening in Çanakkale province, Turkey.
Uludağ A; Uysal A; Uludağ A; Ertekin YH; Tekin M; Kütük B; Silan F; Özdemir Ö
Balkan J Med Genet; 2016 Jul; 19(1):29-34. PubMed ID: 27785405
[TBL] [Abstract][Full Text] [Related]
24. Hemoglobinopathies in the Çukurova Region and Neighboring Provinces.
Yuzbasioglu Ariyurek S; Yildiz SM; Yalin AE; Guzelgul F; Aksoy K
Hemoglobin; 2016 Jun; 40(3):168-72. PubMed ID: 26984585
[TBL] [Abstract][Full Text] [Related]
25. Misdiagnosis of Hb D-Punjab/β-thalassemia is a potential pitfall in hemoglobinopathy screening programs: a case report.
Belhoul KM; Bakir ML; Abdulrahman M
Hemoglobin; 2013; 37(2):119-23. PubMed ID: 23425159
[TBL] [Abstract][Full Text] [Related]
26. Screening for thalassemia and other hemoglobinopathies in a tertiary care hospital of West Bengal: implications for population screening.
Jain BB; Roy RN; Ghosh S; Ghosh T; Banerjee U; Bhattacharya SK
Indian J Public Health; 2012; 56(4):297-300. PubMed ID: 23354142
[TBL] [Abstract][Full Text] [Related]
27. Six-year outcome of the national premarital screening and genetic counseling program for sickle cell disease and β-thalassemia in Saudi Arabia.
Memish ZA; Saeedi MY
Ann Saudi Med; 2011; 31(3):229-35. PubMed ID: 21623050
[TBL] [Abstract][Full Text] [Related]
28. The Prevalence of β-Thalassemia and Other Hemoglobinopathies in Kuwaiti Premarital Screening Program: An 11-Year Experience.
Rouh AlDeen N; Osman AA; Alhabashi MJ; Al Khaldi R; Alawadi H; Alromh MK; Alyafai EG; Akbulut-Jeradi N
J Pers Med; 2021 Sep; 11(10):. PubMed ID: 34683121
[TBL] [Abstract][Full Text] [Related]
29. Incidence of hemoglobinopathies and thalassemias in Northern Alberta. Establishment of reference intervals for HbF and HbA2.
Rodriguez-Capote K; Higgins TN
Clin Biochem; 2015 Jul; 48(10-11):698-702. PubMed ID: 25869492
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of beta-thalassemia trait in premarital screening in Al-Hassa, Saudi Arabia.
Al-Suliman A
Ann Saudi Med; 2006; 26(1):14-6. PubMed ID: 16521869
[TBL] [Abstract][Full Text] [Related]
31. Thalassaemia screening in a non-prevalent region of a prevalent country (Turkey): is it necessary?
Acemoglu H; Beyhun NE; Vancelik S; Polat H; Guraksin A
Public Health; 2008 Jun; 122(6):620-4. PubMed ID: 18222509
[TBL] [Abstract][Full Text] [Related]
32. Screening and diagnosis of hemoglobinopathies in Germany: Current state and future perspectives.
Aramayo-Singelmann C; Halimeh S; Proske P; Vignalingarajah A; Cario H; Christensen MO; Yamamoto R; Röth A; Reinhardt D; Reinhardt HC; Alashkar F
Sci Rep; 2022 Jun; 12(1):9762. PubMed ID: 35697769
[TBL] [Abstract][Full Text] [Related]
33. Knowledge and Attitudes Toward Mandatory Premarital Screening Among University Students in North Jordan.
Alkhaldi SM; Khatatbeh MM; Berggren VE; Taha HA
Hemoglobin; 2016; 40(2):118-24. PubMed ID: 26821551
[TBL] [Abstract][Full Text] [Related]
34. Spectrum of β-Thalassemia and Other Hemoglobinopathies in the Saurashtra Region of Gujarat, India: Analysis of a Large Population Screening Program.
Vachhani NA; Vekariya DJ; Colah RB; Kashiyani HN; Nandani SL
Hemoglobin; 2022 Sep; 46(5):285-289. PubMed ID: 36367309
[TBL] [Abstract][Full Text] [Related]
35. Distribution of Hemoglobinopathy in Nepalese Population.
Shrestha RM; Pandit R; Yadav UK; Das R; Yadav BK; Upreti HC
J Nepal Health Res Counc; 2020 Apr; 18(1):52-58. PubMed ID: 32335593
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of thalassemia and hemoglobinopathy in eastern India: A 10-year high-performance liquid chromatography study of 119,336 cases.
Mondal SK; Mandal S
Asian J Transfus Sci; 2016; 10(1):105-10. PubMed ID: 27011683
[TBL] [Abstract][Full Text] [Related]
37. Pattern of hemoglobinopathies and thalassemias in upper Assam region of North Eastern India: high performance liquid chromatography studies in 9000 patients.
Baruah MK; Saikia M; Baruah A
Indian J Pathol Microbiol; 2014; 57(2):236-43. PubMed ID: 24943756
[TBL] [Abstract][Full Text] [Related]
38. Screening for thalassemia and hemoglobinopathy in a rural area of Thailand: a preliminary study.
Nathalang O; Nillakupt K; Arnutti P; Boonsiri T; Panichkul S; Areekul W
J Med Assoc Thai; 2005 Nov; 88 Suppl 3():S35-42. PubMed ID: 16862674
[TBL] [Abstract][Full Text] [Related]
39. β-Thalassemia in Iran: Things Everyone Needs to Know About This Disease.
Hadipour Dehshal M; Tabrizi Namini M; Hantoushzadeh R; Yousefi Darestani S
Hemoglobin; 2019 May; 43(3):166-173. PubMed ID: 31272240
[TBL] [Abstract][Full Text] [Related]
40. Marked regional variations in the prevalence of sickle cell disease and β-thalassemia in Saudi Arabia: findings from the premarital screening and genetic counseling program.
Memish ZA; Owaidah TM; Saeedi MY
J Epidemiol Glob Health; 2011 Dec; 1(1):61-8. PubMed ID: 23856375
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
